OTCMKTS:BIOAF - biOasis Technologies Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$0.53 +0.01 (+1.07 %)
(As of 05/22/2018 02:24 AM ET)
Previous Close$0.5244
Today's Range$0.53 - $0.53
52-Week Range$0.4499 - $0.9350
Volume1,200 shs
Average Volume7,156 shs
Market Capitalization$27.11 million
P/E RatioN/A
Dividend YieldN/A
Beta0.64

About biOasis Technologies (OTCMKTS:BIOAF)

biOasis Technologies Inc., a development stage biopharmaceutical company, researches, develops, and commercializes technologies and products for the treatment of central nervous system and brain diseases. It develops and commercializes Transcend and Transcendpep platforms for the delivery of therapeutic compounds across the blood-brain barrier and into the central nervous system for the treatment of brain cancers, neurodegenerative, and metabolic diseases. biOasis Technologies Inc. has a collaborative research agreement with CQDM and Brain Canada to perform research on the delivery of therapeutic compounds across the blood-brain barrier; and a research collaboration agreement with Brigham and Women's Hospital Inc., as well as a license agreement with Vaccinex Inc. The company was incorporated in 2006 and is headquartered in Richmond, Canada.

Receive BIOAF News and Ratings via Email

Sign-up to receive the latest news and ratings for BIOAF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drugs, proprietaries, & sundries
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:BIOAF
CUSIPN/A
Phone604-295-7014

Debt

Debt-to-Equity RatioN/A
Current Ratio5.17
Quick Ratio5.17

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$390,000.00
Price / Sales70.25
Cash FlowN/A
Price / CashN/A
Book Value$0.01 per share
Price / Book53.00

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-2,280,000.00
Net Margins-548.15%
Return on Equity-139.01%
Return on Assets-115.81%

Miscellaneous

EmployeesN/A
Outstanding Shares51,690,000

biOasis Technologies (OTCMKTS:BIOAF) Frequently Asked Questions

What is biOasis Technologies' stock symbol?

biOasis Technologies trades on the OTCMKTS under the ticker symbol "BIOAF."

When is biOasis Technologies' next earnings date?

biOasis Technologies is scheduled to release their next quarterly earnings announcement on Wednesday, June, 27th 2018. View Earnings Estimates for biOasis Technologies.

Who are some of biOasis Technologies' key competitors?

Who are biOasis Technologies' key executives?

biOasis Technologies' management team includes the folowing people:
  • Dr. Mark Day, CEO, Pres, Chief Scientist & Director
  • Dr. Wilfred A. Jefferies D.Phil. (Oxon), Scientific Founder and Chairman of Scientific Advisory Board (Age 60)
  • Mr. Christopher P. Lowe M.B.A., Chief Financial Officer and Board Advisor (Age 47)
  • Ms. Catherine London, Exec. VP and Head of Corp. Communications & Investor Relations
  • Mr. Kim Elton, Director of Marketing

Has biOasis Technologies been receiving favorable news coverage?

Press coverage about BIOAF stock has trended somewhat positive this week, according to Accern Sentiment. The research firm identifies positive and negative news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. biOasis Technologies earned a daily sentiment score of 0.11 on Accern's scale. They also gave news stories about the company an impact score of 46.86 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

How do I buy shares of biOasis Technologies?

Shares of BIOAF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is biOasis Technologies' stock price today?

One share of BIOAF stock can currently be purchased for approximately $0.53.

How big of a company is biOasis Technologies?

biOasis Technologies has a market capitalization of $27.11 million and generates $390,000.00 in revenue each year.

How can I contact biOasis Technologies?

biOasis Technologies' mailing address is 10691 SHELLBRIDGE WAY SUITE 130, RICHMOND A1, V6X 2W8. The company can be reached via phone at 604-295-7014 or via email at [email protected]


MarketBeat Community Rating for biOasis Technologies (BIOAF)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  9 (Vote Outperform)
Underperform Votes:  14 (Vote Underperform)
Total Votes:  23
MarketBeat's community ratings are surveys of what our community members think about biOasis Technologies and other stocks. Vote "Outperform" if you believe BIOAF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BIOAF will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

biOasis Technologies (OTCMKTS:BIOAF) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
(Data available from 5/22/2016 forward)

Earnings

biOasis Technologies (OTCMKTS:BIOAF) Earnings History and Estimates Chart

Earnings by Quarter for biOasis Technologies (OTCMKTS:BIOAF)

biOasis Technologies (OTCMKTS BIOAF) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
6/27/2018        
10/31/2017Q2 2018($0.02)$0.12 millionViewN/AView Earnings Details
7/31/2017Q1 2018($0.01)$0.16 millionViewN/AView Earnings Details
6/28/2017Q4 2017($0.01)$0.08 millionViewN/AView Earnings Details
1/30/2017Q3 2017($0.01)$0.10 millionViewN/AView Earnings Details
10/28/2016Q2 2017($0.02)$0.09 millionViewN/AView Earnings Details
7/29/2016Q1 2017($0.02)$0.12 millionViewN/AView Earnings Details
6/28/2016Q4 2016($0.01)$0.10 millionViewN/AView Earnings Details
1/28/2016Q3 2016($0.01)$0.05 millionViewN/AView Earnings Details
10/30/2015Q2 2016($0.01)ViewN/AView Earnings Details
7/28/2015Q1 2016($0.01)ViewN/AView Earnings Details
1/27/2015Q3 2015($0.01)ViewN/AView Earnings Details
10/29/2014Q2 2015($0.02)ViewN/AView Earnings Details
7/30/2014Q1 2015($0.02)ViewN/AView Earnings Details
6/18/2014Q4 2014($0.03)ViewN/AView Earnings Details
1/22/2014Q3 2014($0.02)($0.02)ViewN/AView Earnings Details
10/21/2013Q2 2014($0.02)($0.02)ViewN/AView Earnings Details
7/22/2013Q1 2014($0.02)($0.02)ViewN/AView Earnings Details
6/17/2013Q4 2013($0.02)($0.03)ViewN/AView Earnings Details
1/23/2013Q3 2013($0.02)($0.04)ViewN/AView Earnings Details
10/25/2012Q2 2013($0.02)($0.04)ViewN/AView Earnings Details
7/27/2012Q1 2013($0.02)($0.02)ViewN/AView Earnings Details
6/25/2012Q4 2012($0.02)($0.03)ViewN/AView Earnings Details
1/26/2012Q3 2012($0.02)($0.03)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

biOasis Technologies (OTCMKTS:BIOAF) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

biOasis Technologies (OTCMKTS BIOAF) Insider Trading and Institutional Ownership History

Insider Trading History for biOasis Technologies (OTCMKTS:BIOAF)

biOasis Technologies (OTCMKTS BIOAF) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

biOasis Technologies (OTCMKTS BIOAF) News Headlines

Source:

SEC Filings

biOasis Technologies (OTCMKTS:BIOAF) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

biOasis Technologies (OTCMKTS BIOAF) Stock Chart for Tuesday, May, 22, 2018

Loading chart…

This page was last updated on 5/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.